Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to … [Read more...] about 100,000 Fast PCR Tests to Detect Covid-19 Donated to Hospitals Worldwide
Blog
Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world
Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to rapidly identify the presence of these variants. SARS-CoV-2 belongs to a group of RNA viruses that exhibit spontaneous mutations. Some alarming variants have recently … [Read more...] about Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world
Massive capacity detecting and monitoring new variants of SARS-CoV-2
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2 The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United … [Read more...] about Massive capacity detecting and monitoring new variants of SARS-CoV-2
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa. Eurofins is pleased to announce the … [Read more...] about Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
Cost-effective SARS-CoV-2 full-length viral genome sequencing services
Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations … [Read more...] about Cost-effective SARS-CoV-2 full-length viral genome sequencing services
Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations
Eurofins Genomics launches an optimized, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo mix synthesized by Eurofins Genomics’ Synthesis branch will also be commercially available shortly. The new NGS service and ARTIC NGS oligo kit are Eurofins’ latest additions to a comprehensive product portfolio to … [Read more...] about Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations
Eurofins launches COVID-19 PCR tests with at-home self-sampling options
Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK. … [Read more...] about Eurofins launches COVID-19 PCR tests with at-home self-sampling options
Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK
On 19 October 2020 Eurofins launched EmpowerDX SARS CoV 2 RT PCR test with at home sampling option after it received an Emergency Use Authorization (EUA) by the FDA. Demand for the testing kit available at empowerdxlab.com is increasing significantly week on week. To make patient sampling easier by non-healthcare professionals and especially for testing children, Eurofins validated a sampling … [Read more...] about Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK
No Deal Brexit Mitigation
Post-Brexit trade talks are continuing after negotiators failed to reach an agreement over the weekend. It is understood there is likely to be a decision before Christmas on whether or not a deal can be reached. … [Read more...] about No Deal Brexit Mitigation
Eurofins Partners with Insurance Providers on At-Home COVID-19 Test
Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being covered by Medicare, Medicaid and commercial insurance providers. The Emergency Use Authorization (“EUA”) authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email link within 24 hours of … [Read more...] about Eurofins Partners with Insurance Providers on At-Home COVID-19 Test